Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Synta Pharmaceuticals Corp. has named Anne Whitaker as president, chief executive officer and a member of the company's board of directors, effective September 2, 2014. She has more than 20 years of experience in the pharmaceutical...

Allergan, Inc. reported on August 1 that it had filed a lawsuit in the United States District Court for the Central District of California against Valeant Pharmaceuticals International, Inc., Pershing Square Capital Management,...

The specialty pharmaceutical company Impax Laboratories, Inc. announced that the US Food and Drug Administrationperformed a re-inspection of the company's Hayward, California manufacturing facility from June 16 to July 31, 2014. At the conclusion...

Roche has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark. Santaris Pharma's key technology is its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging...

Medivir, a Stockholm-based pharmaceutical company, has entered into a license agreement with Boehringer Ingelheim International GmbH for exclusive, global rights to a drug program for the treatment and prevention of respiratory syncytial virus...

AbbVie reports that the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody...